{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04134728: Phase 3 Interventional Completed Arthritis, Rheumatoid
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04058028: Phase 2 Interventional Completed Systemic Lupus Erythematosus (SLE)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04665856: Phase 3 Interventional Active, not recruiting Small Cell Lung Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472145: Phase 2/Phase 3 Interventional Completed Leukemia, Myeloid, Acute
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sirtratumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:loncastuximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03574545: Phase 1 Interventional Completed Rheumatoid Arthritis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02859961: Phase 2/Phase 3 Interventional Completed HIV
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:torudokimab [INN]
Source URL:
Class:
PROTEIN
